Skip to content
crommelin

Seminar Title

 

Synergy Satellite: Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? (supported by an educational grant from Roche)

Affiliation

Utrecht University

Country

The Netherlands

1. Current Status, Position

Prof. Dr. (Pharmacy) Daan Crommelin is emeritus-professor at the Department of Pharmaceutics at Utrecht University.

2. Education

Until December 2011 Prof. Crommelin was scientific director of the Dutch Top Institute Pharma in Leiden. He is adjunct professor at the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. Crommelin is co-founder of OctoPlus, a Leiden based company specialized in the development of pharmaceutical (mainly protein based) product formulations and advanced drug delivery systems. 

3. Research Area

Prof. Crommelin published extensively and is on the editorial board of 10 peer reviewed journals in the pharmaceutical sciences. He is Editor-in-Chief of the AAPS book series ‘Advances in the Pharmaceutical Sciences’. He also advises venture capital groups. He chaired the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (F.I.P.), was chair of the organizing committee of the Pharmaceutical Sciences World Conference 2007 in Amsterdam. He is past president of the European Federation of Pharmaceutical Sciences (EUFEPS) and past vice-chair of the scientific advisory board of the European Innovative Medicines Initiative (IMI).

4. Conflict of interest: none

×

Join us in Prague at the special rate of
350 Euro*(+ 21% Czech VAT)
to promote
WORLD PHARMACIST DAY 2025!

Secure your spot (only 45 seats available!)

*instead of 400 Euro – Offer available from 25/09 at 00h01 to 30/09 at 23h59 CET

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.